Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    20979470 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
Conditions: Atrial Fibrillation;   Vascular Risk
Interventions: Drug: clopidogrel (SR25990C);   Drug: placebo
To Top

† Indicates status has not been verified in more than two years